Ophthalmology
Long-Term Data on Ex-Press Shunt for Uncontrolled Glaucoma Are Very Promising
- The Ex-Press mini glaucoma shunt has been available internationally for nearly 20 years with nearly 100,000 implantations worldwide.
- Safety and efficacy have become well established
- Clinical outcomes appear to be significantly superior to trabeculectomy.
- Relatively high cost of the Ex-Press shunt may be an important barrier to more widespread implementation.
- The device is referred to as a “glaucoma filtration device” by the manufacturer.
